Technical Analysis for AKTX - Akari Therapeutics Plc

Grade Last Price % Change Price Change
grade C 1.85 -3.65% -0.07
AKTX closed down 3.65 percent on Friday, January 18, 2019, on 21 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Down
See historical AKTX trend table...

Date Alert Name Type % Chg
Jan 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Jan 17 200 DMA Resistance Bearish -3.65%
Jan 17 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.65%
Jan 17 Upper Bollinger Band Walk Strength -3.65%
Jan 17 Inside Day Range Contraction -3.65%
Jan 17 Overbought Stochastic Strength -3.65%
Jan 16 Fell Below 200 DMA Bearish -3.14%
Jan 16 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.14%
Jan 16 Upper Bollinger Band Walk Strength -3.14%
Jan 16 Outside Day Range Expansion -3.14%

Older signals for AKTX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Akari Therapeutics, Plc is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of therapeutics to treat rare and orphan autoimmune and inflammatory diseases. The company develops Coversin, a second-generation complement inhibitor that acts on complement component-C5, preventing release of C5a and formation of C5b – 9 (membrane attack complex or MAC). It develops products to treat rare diseases, such as paroxysmal nocturnal haemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), myasthenia gravis (MG), Guillain Barré syndrome (GBS), and Sjögren's syndrome. The company was formerly known as Volution Immuno Pharmaceuticals SA and changed its name to Akari Therapeutics, Plc in September 2015. The company is based in New York, New York. Akari Therapeutics, Plc operates as a subsidiary of RPC Pharma Limited.
Is AKTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.56
52 Week Low 1.56
Average Volume 22,421
200-Day Moving Average 1.9336
50-Day Moving Average 1.7842
20-Day Moving Average 1.7983
10-Day Moving Average 1.898
Average True Range 0.1133
ADX 20.36
+DI 17.2727
-DI 20.3478
Chandelier Exit (Long, 3 ATRs ) 1.7101
Chandelier Exit (Short, 3 ATRs ) 1.8999
Upper Bollinger Band 2.044
Lower Bollinger Band 1.5526
Percent B (%b) 0.61
BandWidth 27.325808
MACD Line 0.0446
MACD Signal Line 0.03
MACD Histogram 0.0145
Fundamentals Value
Market Cap 21.78 Million
Num Shares 11.8 Million
EPS -2.00
Price-to-Earnings (P/E) Ratio -0.93
Price-to-Sales 0.00
Price-to-Book 2.11
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.03
Resistance 3 (R3) 2.04 1.98 2.00
Resistance 2 (R2) 1.98 1.94 1.98 1.99
Resistance 1 (R1) 1.92 1.91 1.89 1.91 1.98
Pivot Point 1.86 1.86 1.85 1.86 1.86
Support 1 (S1) 1.80 1.82 1.77 1.79 1.72
Support 2 (S2) 1.74 1.79 1.74 1.71
Support 3 (S3) 1.68 1.74 1.70
Support 4 (S4) 1.67